In addition, apatinib treatment increased apoptosis-related proteins expression, decreased cell proliferation-related proteins expression, and inhibited SHH pathway proteins expression in gastric tumors (Figure 7E and Supplementary Figures 6C–E). This evidence concerns the gene SHH and gastric neoplasm.